Article discusses how Dutasteride, a medication being tested by Glaxo-SmithKline, may help restore hair loss.

Study found that the alpha-reductase inhibitor suppressed dihydrotestosterone, a hormone which plays a key role in benign prostatic hyperplasia.

Discussion of the treatment for benign prostatic hyperplasia (BPH) and male pattern baldness compares the drug to finasteride (Propecia).

View a diagram of the dual alpha-reductase inhibitor's chemical structure and browse a summary of study results on its effectiveness.

Baldness support group discusses the results of Phase II studies of the treatment for male pattern baldness and enlarged prostate.